Heterotypic canine parvovirus vaccine

Details Heterotypic canine parvovirus vaccine Heterotypic canine parvovirus vaccine

1979-02-16

1980-03-18

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

A61K 3912

Patent

active

041939905

ABSTRACT:
A vaccine against disease caused by canine parvoviruses (CPV) is produced using a modified live (attenuated) or chemically inactivated feline panleukopenia virus vaccine.

REFERENCES:
patent: 2136131 (1938-11-01), Green
patent: 2271818 (1942-02-01), Green
patent: 2271819 (1942-02-01), Green
patent: 3285817 (1966-11-01), Slater
patent: 3293130 (1966-12-01), Slater et al.
patent: 3346456 (1967-10-01), Baker
patent: 3465077 (1969-02-01), Baker
patent: 3520972 (1970-07-01), Smith et al.
patent: 3562387 (1971-02-01), Laverman
patent: 3577525 (1971-05-01), Baker
Binn, L. N. et al., Infection and Immunity 1(5):503-508, "Recovery and Characterization of a Minute Virus of Canines" (1970).
Siegl, G., "The Parvoviruses" in Virology Monographs #15, Springer-Verlag Wien, N.Y., p. 71 (1976).
Eugster, A. K. et al., Southwestern Veterinarian 30(1):59-60 (1977), "Diarrhea in Puppies: Parvovirus-Like Particles Demonstrated in Their Feces".

Affiliated with

Also associated with

Rating

Heterotypic canine parvovirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterotypic canine parvovirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterotypic canine parvovirus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1124167